You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 202789


✉ Email this page to a colleague

« Back to Dashboard


NDA 202789 describes ISIBLOOM, which is a drug marketed by Xiromed and is included in one NDA. It is available from two suppliers. Additional details are available on the ISIBLOOM profile page.

The generic ingredient in ISIBLOOM is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 202789
Tradename:ISIBLOOM
Applicant:Xiromed
Ingredient:desogestrel; ethinyl estradiol
Patents:0
Suppliers and Packaging for NDA: 202789
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISIBLOOM desogestrel; ethinyl estradiol TABLET;ORAL-28 202789 ANDA Par Pharmaceutical, Inc. 0254-2033 0254-2033-73 3 CARTON in 1 CARTON (0254-2033-73) / 1 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK
ISIBLOOM desogestrel; ethinyl estradiol TABLET;ORAL-28 202789 ANDA Par Pharmaceutical, Inc. 0254-2033 0254-2033-80 6 CARTON in 1 CARTON (0254-2033-80) / 1 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.15MG;0.03MG
Approval Date:Aug 12, 2015TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.